Interestingly, these findings are consistent with the meta-analyses suggesting metformin is linked to decreased incidence of colorectal cancer along with the finding that elevated AMPKα1 activity is seen frequently in colorectal adenocarcinomas [7]. This evidence concerns the gene PRKAA1 and colorectal adenocarcinoma.